Eli Lilly and Company

Nov 18, 09
	NEW STORY
13:11 ET	New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
Nov 16, 09
08:00 ET	Lilly Surpasses United Way 2009 Campaign Goal
Nov 15, 09
15:00 ET	Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
Nov 13, 09
09:00 ET	Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Nov 11, 09
09:00 ET	Deadline Extended to December 16 to Submit Nominations for Depression Awards Program
Nov 09, 09
14:01 ET	Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day
Nov 04, 09
14:27 ET	Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer
Oct 30, 09
16:00 ET	Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
Oct 29, 09
15:45 ET	Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
10:30 ET	Lilly Expands Disease Management Program to Reach Growing Asian-American Population
Oct 27, 09
08:00 ET	November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers
Oct 21, 09
09:00 ET	Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
08:30 ET	Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
06:30 ET	Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Oct 19, 09
16:30 ET	Lilly Declares Fourth-Quarter Dividend
Oct 14, 09
09:00 ET	Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
08:00 ET	New Survey Reveals Even After 12 Years of Living With Depression Adults Still Struggle Due to Lack of Basic Information
Oct 06, 09
12:00 ET	Lilly Confirms Date and Conference Call for Third-Quarter 2009 Financial Results Announcement
Sep 29, 09
09:00 ET	The Lilly TB Drug Discovery Initiative Announces New Collaborator
Sep 28, 09
08:00 ET	Lilly Receives Honor from Lambda Legal
Sep 24, 09
09:00 ET	NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care
09:00 ET	The Welcome Back Awards Seeks Nominations to Recognize Those Dedicated to the Depression Community
Sep 23, 09
19:12 ET	U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014
Sep 22, 09
09:23 ET	Survivors of Heart Events: What Does it Take to Get Back to Living?
09:15 ET	Lilly Announces New U.S. Affiliate Leader
Sep 21, 09
09:00 ET	Lilly Receives 100 Percent Rating on Corporate Equality Index Survey
07:00 ET	Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
Sep 14, 09
09:30 ET	Lilly Names New Business Leaders
09:00 ET	Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
Sep 11, 09
11:26 ET	New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Sep 08, 09
14:04 ET	Know Fibro Initiative Commemorates National Pain Awareness Month
Sep 02, 09
11:01 ET	Lilly Named Best Company for Blacks in Technology
Aug 31, 09
10:30 ET	Eight out of 10 People Diagnosed With Heart Disease Consider Their Diagnosis a 'Wake-Up Call'
Aug 24, 09
10:00 ET	Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes
Aug 18, 09
16:15 ET	Lilly Reports on Outcome of Phase III Study of Arzoxifene
Aug 17, 09
20:01 ET	U.S. District Court Rules Against Lilly Regarding Gemzar Patent
Aug 05, 09
09:00 ET	Effient(TM) is Now Available in Pharmacies
08:00 ET	Lilly Broadens Income Eligibility for Patient Assistance Programs
Jul 31, 09
07:57 ET	Lilly Announces Continued Commitment to Transparency with Faculty Registry
Jul 27, 09
17:00 ET	Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
08:00 ET	Lilly Receives Award From National Medical Association
08:00 ET	Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
Jul 23, 09
10:44 ET	FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
Jul 22, 09
06:30 ET	Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
Jul 21, 09
09:30 ET	National Report Ranks Oklahoma as a Top State for Mental Health Services
Jul 10, 09
16:43 ET	Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
10:37 ET	ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
08:00 ET	Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
Jul 06, 09
16:30 ET	Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
09:00 ET	Top 10 Tips for Staying Healthy When Money is Tight
08:00 ET	Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
Jun 22, 09
17:01 ET	Lilly Declares Third-Quarter Dividend
Jun 15, 09
09:00 ET	Eli Lilly and Company Announces New Drug Discovery Initiative
Jun 10, 09
18:30 ET	FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
Jun 08, 09
09:00 ET	Successful Disease Management Programs Can Play Role in Health Care Reform
Jun 07, 09
09:15 ET	Exenatide Once Weekly Provided Sustained Improvements in Glycaemic Control with Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
Jun 06, 09
11:00 ET	Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
Jun 05, 09
06:30 ET	Bart Peterson to Join Lilly Leadership Team
Jun 03, 09
08:00 ET	Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Jun 02, 09
09:00 ET	R. David Hoover Elected to Lilly Board of Directors
May 31, 09
08:30 ET	Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
May 29, 09
13:09 ET	ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
May 21, 09
09:00 ET	Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
07:00 ET	Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
May 19, 09
11:00 ET	Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management
May 18, 09
13:30 ET	Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
09:47 ET	Lilly to Celebrate Second Annual Global Day of Service May 20
May 15, 09
10:00 ET	Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community
May 14, 09
12:05 ET	Lilly Chairman & CEO Lechleiter Says Innovation Is Vital-But-Missing Plank in Health Reform Debate
May 12, 09
08:00 ET	Lilly Set to Unveil More Than 50 Studies at ASCO 2009
May 11, 09
09:00 ET	Groundbreaking Diabetes Disease Management Program Honored With URAC National Best Practices Award
May 06, 09
08:00 ET	Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
May 05, 09
10:00 ET	Lilly USA, LLC and Vision Racing Encourage Fans to get on Track With Their Health
07:00 ET	New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel
Apr 22, 09
19:30 ET	Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Apr 20, 09
16:25 ET	Lilly Declares Second-Quarter Dividend
06:30 ET	Lilly Reports Strong First-Quarter 2009 Results
Apr 17, 09
10:12 ET	Lilly Names Susan Mahony Senior Vice President of Human Resources
Apr 08, 09
15:49 ET	Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
15:10 ET	J. Michael Cook to Retire from Lilly Board of Directors
Apr 06, 09
17:08 ET	Lilly Sets Date and Conference Call for First-Quarter 2009 Financial Results Announcement
Apr 03, 09
16:39 ET	U.S. Appeals Court Issues Ruling in Support of Lilly in Ariad Patent Litigation
Mar 29, 09
13:00 ET	Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
Mar 27, 09
09:00 ET	Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes
Mar 23, 09
07:00 ET	FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
07:00 ET	Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
Mar 17, 09
17:16 ET	Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
Mar 09, 09
18:40 ET	Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Mar 04, 09
12:00 ET	Lilly's Anthony Murphy Announces Retirement
Mar 02, 09
10:00 ET	Lilly Announces Leadership Changes
Feb 23, 09
09:00 ET	Grammy-nominated Singer Angie Stone Encourages African-Americans in Birmingham to Fearlessly FACE Diabetes
07:21 ET	European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Feb 18, 09
12:00 ET	Ralph Alvarez Elected to Lilly Board of Directors
Feb 03, 09
18:08 ET	Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Jan 30, 09
08:00 ET	Lilly Announces Senior Leadership Change
06:00 ET	Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Jan 29, 09
06:30 ET	Lilly Reports Fourth-Quarter and Full-Year 2008 Results
Jan 16, 09
14:47 ET	Lilly to Sponsor Martin Luther King Day 'I AM CHANGE' Campaign as Part of Inaugural Gift to President-Elect Obama
Jan 15, 09
06:05 ET	Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Jan 12, 09
17:26 ET	Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition
Jan 07, 09
18:12 ET	FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
12:30 ET	Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement
Dec 31, 08
08:14 ET	FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
Dec 18, 08
16:00 ET	Lilly Foundation Provides $50,000 Donation to Gleaners Food Bank
13:06 ET	Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP)
Dec 15, 08
15:45 ET	Lilly Announces Dividend Increase
Dec 12, 08
13:00 ET	Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies
Dec 11, 08
06:30 ET	Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
06:30 ET	Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
Dec 10, 08
09:00 ET	Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Dec 08, 08
13:50 ET	Lilly Global Day of Service Receives National and Local Recognition
Nov 28, 08
08:00 ET	Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Nov 24, 08
09:28 ET	Lilly Completes Acquisition of ImClone Systems
08:00 ET	Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program
Nov 21, 08
08:24 ET	Lilly Completes Cash Tender Offer for ImClone Systems
Nov 19, 08
12:12 ET	Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
Nov 18, 08
15:04 ET	Lilly Diabetes, International Diabetes Federation and International Society of Pediatric and Adolescent Diabetes Announce the 2nd Annual Inspired by Diabetes Creative Expression Competition
Nov 17, 08
07:00 ET	Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
Nov 13, 08
11:30 ET	Lilly Contributes $11.1 Million to United Way Annual Campaign
Nov 12, 08
13:00 ET	Lilly Diabetes Partners with the International Diabetes Federation and Healthy Interactions to Launch Conversation Map(TM) Tools in Latin America
09:00 ET	Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
08:00 ET	Deadline Extended to Submit Nominations for Depression Awards Program
Nov 09, 08
09:30 ET	Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
Oct 30, 08
09:00 ET	American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes
Oct 28, 08
10:00 ET	Teach For America and Lilly Launch Program to Match Lilly Employees with Teachers in Underserved Public Schools
Oct 27, 08
08:30 ET	From Pain to Unexpected Fame: One Woman's Journey to Know Fibro
08:00 ET	Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
Oct 24, 08
06:00 ET	European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
Oct 23, 08
08:00 ET	Winning Entry from Oncology On Canvas(SM) Art Competition Depicts Survivorship Despite Breast Cancer; Wholeness Despite Mastectomy
06:30 ET	Lilly Reports Third-Quarter Results
Oct 20, 08
15:30 ET	Lilly Declares Fourth-Quarter Dividend
14:45 ET	Douglas Oberhelman Elected to Lilly Board of Directors
Oct 16, 08
23:15 ET	Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
Oct 15, 08
08:00 ET	Lilly Launches New FORTEO Delivery Device
Oct 14, 08
08:00 ET	Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Oct 10, 08
16:10 ET	Healthcare Resources Available in Difficult Times
08:00 ET	Lilly Recognized as One of the World's Top Biopharmaceutical Employers
Oct 07, 08
16:00 ET	Lilly Sets Date and Conference Call for Third Quarter 2008 Financial Results Announcement
12:50 ET	Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
08:06 ET	Eli Lilly and Company Resolves Investigation Involving Numerous States
Oct 06, 08
06:53 ET	Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Oct 03, 08
08:00 ET	Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
Oct 01, 08
08:00 ET	Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
Sep 29, 08
08:59 ET	FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
Sep 26, 08
17:00 ET	FDA Continues to Review Prasugrel New Drug Application
06:00 ET	CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Sep 24, 08
10:30 ET	Lilly to Sponsor Congressional Black Caucus Foundation's Annual Legislative Conference
08:00 ET	Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments
Sep 18, 08
08:00 ET	John Lechleiter Named Chairman of Lilly's Board of Directors
Sep 09, 08
07:30 ET	First Reported Head-to-Head Study Showed BYETTA(R) (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia(TM) (sitagliptin) in Patients With Type 2 Diabetes
Sep 03, 08
03:16 ET	Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
02:46 ET	New Crossover Study Shows Prasugrel Significantly Reduced Platelet Aggregation in Patients with Acute Coronary Syndromes Compared with Clopidogrel at High Doses
Sep 02, 08
10:00 ET	Elanco Announces Location for New Global Headquarters in Hancock County
08:19 ET	Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
03:30 ET	Survey Highlights How Family Support and Finding and Staying on the Right Treatment Can Make a Difference in Keeping Patients with Serious Mental Illness Well
Aug 31, 08
09:23 ET	Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
Aug 25, 08
17:00 ET	Lilly and Amylin Set Date and Time for Conference Call
07:30 ET	Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Aug 22, 08
02:00 ET	Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Aug 21, 08
08:00 ET	Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
Aug 20, 08
13:23 ET	Lilly Announces Completion of SGX Acquisition
09:00 ET	Elanco Announces Acquisition of Posilac(R) Dairy Business
Aug 06, 08
09:00 ET	Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies
Aug 04, 08
08:00 ET	Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
Jul 30, 08
16:00 ET	Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Jul 24, 08
09:00 ET	Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country
07:00 ET	Lilly Reports Solid Second-Quarter Results
Jul 16, 08
08:00 ET	The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds
Jul 13, 08
09:00 ET	Lilly Partners With the National Council of La Raza to Fight Chronic Disease
Jul 10, 08
09:00 ET	Lilly Supports Industry Code on Interactions with Healthcare Professionals
Jul 08, 08
16:05 ET	Lilly to Acquire SGX Pharmaceuticals
Jun 27, 08
10:00 ET	Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Campaign
02:00 ET	European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Jun 25, 08
16:20 ET	Lilly Sets Date and Conference Call for Second Quarter 2008 Financial Results Announcement
Jun 23, 08
18:30 ET	FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
02:00 ET	Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
Jun 16, 08
08:00 ET	FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Jun 13, 08
08:00 ET	Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Jun 12, 08
08:00 ET	Lilly and TransPharma Medical Announce Licensing and Development Agreement
Jun 10, 08
12:43 ET	Lilly's Connelly Appointed to the President's Commission on White House Fellowships
Jun 09, 08
20:50 ET	After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
11:53 ET	Lilly to Provide Aid to Indiana Tornado and Flood Victims
08:00 ET	When Words Fail ... Cancer Art Competition Gives Rise to Expression and Hope
Jun 07, 08
13:00 ET	Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
12:00 ET	Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
Jun 05, 08
09:39 ET	Inspired by Diabetes U.S. National Contest Winners Share Stories of Perseverance and Success in Managing Diabetes
May 29, 08
08:00 ET	Art Exhibit Honors National Cancer Survivors Day
08:00 ET	Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
May 28, 08
07:00 ET	Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
May 21, 08
10:00 ET	Lilly Announces Changes in Key Leadership Roles
May 20, 08
10:44 ET	Lilly to Provide More Than $1 Million in Disaster Aid
May 19, 08
10:30 ET	American Psychiatric Foundation, Lilly Foundation and Give an Hour Join Forces to Provide Mental Health Care to Iraq and Afghanistan Veterans
May 15, 08
21:00 ET	ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
20:00 ET	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
05:00 ET	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
May 14, 08
13:33 ET	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
May 13, 08
14:55 ET	Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
11:55 ET	More Than 8,400 Lilly Employees to Participate in Massive One-Day City Makeover May 15
May 12, 08
11:00 ET	Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
May 08, 08
08:18 ET	FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
May 02, 08
08:00 ET	2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression
May 01, 08
09:19 ET	Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
Apr 30, 08
13:00 ET	Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs
13:00 ET	Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
Apr 21, 08
14:57 ET	Lilly Declares Second-Quarter Dividend
06:30 ET	Lilly Reports Solid First-Quarter Results
Apr 16, 08
14:31 ET	Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards
10:35 ET	Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Apr 15, 08
09:00 ET	Neo-Soul Singer Angie Stone Belts a New Tune: Be Fearless in the FACE of Diabetes
Apr 04, 08
03:00 ET	FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
Apr 02, 08
12:00 ET	Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
Mar 31, 08
04:00 ET	Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Mar 29, 08
09:01 ET	Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Mar 26, 08
17:09 ET	Lilly Sets Date and Conference Call for First Quarter 2008 Financial Results Announcement
Mar 14, 08
21:42 ET	Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use'
Mar 13, 08
17:26 ET	Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Mar 12, 08
17:39 ET	Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
04:00 ET	Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
Mar 11, 08
08:00 ET	Lilly Offers Helping Hand in Fight Against Chronic Disease
Mar 07, 08
17:09 ET	Lilly Announces Termination of AIR Insulin Program
Mar 05, 08
15:55 ET	Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says
Feb 28, 08
08:16 ET	FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Feb 26, 08
11:00 ET	Lilly and Partners In Health, Brigham and Women's Hospital Team Up to Fight MDR-TB in Former Soviet Republics
Feb 21, 08
16:53 ET	FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
Feb 19, 08
09:19 ET	Michael L. Eskew Elected to Lilly Board of Directors
Feb 06, 08
18:35 ET	FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Jan 29, 08
07:00 ET	Lilly Caps Successful Year with Strong Fourth-Quarter Results
Jan 18, 08
11:41 ET	In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Jan 08, 08
09:30 ET	FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Jan 04, 08
12:01 ET	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
08:01 ET	Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
Dec 18, 07
07:30 ET	Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor
Dec 17, 07
16:30 ET	Lilly and BioMS Medical Announce Global Licensing and Development Agreement
16:10 ET	Lilly Announces Dividend Increase
Dec 14, 07
11:00 ET	Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
Dec 06, 07
06:30 ET	Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
Dec 05, 07
09:15 ET	Lilly Announces New President of Animal Health Division
09:00 ET	Lilly Announces Pat James to Assume New Role
Nov 30, 07
10:00 ET	FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Nov 29, 07
05:00 ET	International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Nov 15, 07
08:00 ET	When Words Fail ... Cancer Patients Unite to Express Their Journeys on Canvas
07:30 ET	Eli Lilly and Company to Receive Honor from National Urban League
Nov 14, 07
17:00 ET	FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Nov 13, 07
08:30 ET	Deadline Extended to Submit Nominations for 10th Anniversary of Depression Awards Program
Nov 09, 07
01:00 ET	The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
Nov 06, 07
12:04 ET	Lilly Contributes $10.8 Million to United Way Annual Campaign
10:00 ET	NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes
09:00 ET	Lilly Receives NCQA Design Certification for Depression Care Management Program
Oct 31, 07
08:00 ET	2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Importance of Early Detection
Oct 30, 07
18:20 ET	Lilly Sets Date and Time for American Heart Association Conference Call
06:00 ET	Lilly and Glenmark Pharmaceuticals Announce License Agreement
Oct 29, 07
09:00 ET	Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Oct 26, 07
17:29 ET	Eli Lilly and Company Aids California Recovery Effort
Oct 24, 07
16:35 ET	Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
Oct 18, 07
07:00 ET	Lilly Delivers Strong Third-Quarter Results
07:00 ET	Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Oct 05, 07
07:00 ET	Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Oct 02, 07
12:00 ET	Lilly's CEO Calls for Reform of Nation's Drug Safety System
Sep 25, 07
07:00 ET	Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
02:00 ET	Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Sep 20, 07
11:30 ET	Lilly Sets Date and Conference Call for Third Quarter 2007 Financial Results Announcement
07:45 ET	Baseline Data From European Observational Study Highlights Characteristics of Patients with Type 2 Diabetes Initiating Insulin
Sep 18, 07
14:00 ET	Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
08:00 ET	The Welcome Back Awards Now Accepting Nominations to Honor Courageous Individuals Dedicated to the Depression Community
06:00 ET	European Study Outlines Struggle to Control Diabetes, Significant Economic Implications to Healthcare Systems
Sep 07, 07
14:08 ET	Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
Sep 04, 07
21:30 ET	Data Affirm Benefit of ALIMTA (R) (pemetrexed for injection) for Patients With Malignant Pleural Mesothelioma
Sep 03, 07
20:30 ET	Data Affirm Benefit of ALIMTA(R) (pemetrexed for injection) for Patients with Non-Small Cell Lung Cancer
Sep 02, 07
13:00 ET	Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
Aug 21, 07
08:00 ET	New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Jul 24, 07
12:56 ET	FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women
06:00 ET	Lilly Reports Strong Second-Quarter Results; Raises Full-Year Sales and EPS Guidance
Jul 11, 07
10:00 ET	European Commission Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the Treatment of Osteoporosis in Men
Jul 10, 07
10:00 ET	Breast Cancer Survivor Jaclyn Smith Urges Women to Know Their Breast Cancer Risk Factors
Jul 04, 07
13:30 ET	Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Jun 29, 07
14:30 ET	Lilly Sets Date and Conference Call for Second Quarter 2007 Financial Results Announcement
Jun 21, 07
14:03 ET	Lilly Declares Third-Quarter Dividend
10:18 ET	Lilly, International Diabetes Federation and American Diabetes Association Announce U.S. Launch of 'Inspired by Diabetes' Creative Expression Competition
Jun 20, 07
15:59 ET	Academy of Family Physicians Foundation Will Launch New Model of Peer Support to Drive Behavior Changes in People with Diabetes
11:00 ET	Chicago Community Leaders Come Together to Confront the Diabetes Epidemic
Jun 13, 07
13:30 ET	Lilly Unveils Ambitious Partnership for Tuberculosis Drug Discovery
09:00 ET	Lilly Tuberculosis Partnership Honored By Global Business Coalition
08:00 ET	Dale M. Edgar, Ph.D., to Join Lilly; Will Head Lilly Research Lab's Discovery Sleep Research Efforts
Jun 07, 07
10:00 ET	Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents
Jun 06, 07
08:04 ET	Lilly Partners With the Make-A-Wish Foundation(R) of Greater Ohio, Kentucky & Indiana, Indiana Region to Grant Four Local Wishes
Jun 05, 07
08:00 ET	National Campaign Showcases the Importance of Joining Forces With 'Man's Best Friend' in Overcoming Depression
Jun 02, 07
16:00 ET	Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
15:00 ET	Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
09:00 ET	Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
Jun 01, 07
14:00 ET	Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
08:00 ET	Lilly Announces a Call for Articles Into 2007 Luminous Award
May 25, 07
09:00 ET	Lilly Announces Senior Leadership Change in Manufacturing
May 23, 07
20:00 ET	In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, In Reducing Painful Symptoms in SSRI Non- or Partial-responders with Depression
20:00 ET	Workplace Burden of Depression Magnified by Co-morbid Fatigue and Anxiety, New Study Shows
15:00 ET	Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
08:00 ET	Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
May 21, 07
15:11 ET	Data Suggest Cymbalta(R) Improved Functioning in Patients with Generalized Anxiety Disorder
May 09, 07
08:00 ET	Lilly Announces New Employee Policy
May 04, 07
14:00 ET	Lilly Announces Senior Leadership Changes
May 03, 07
08:05 ET	Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
May 01, 07
08:00 ET	Lilly to Publish Information on Grants and Contributions
Apr 20, 07
08:00 ET	In The Top 10 Most Romantic Cities, Spring is Here and Boomer Couples are Ready!
Apr 19, 07
09:30 ET	New Survey Shows Most Physicians Believe Diabetes Patients Are Not Receiving Appropriate Care For Diabetic Nerve Pain
Apr 16, 07
15:45 ET	Lilly Declares Second-Quarter Dividend
09:00 ET	Lilly and the AACR Work Together To Recognize Breakthrough Research in the Fight Against Cancer
06:48 ET	Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales and EPS Guidance
Apr 15, 07
09:00 ET	Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Apr 03, 07
11:12 ET	Lilly Announces Completion of Hypnion Acquisition
08:00 ET	New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
Mar 29, 07
08:00 ET	Lilly Sets Date and Conference Call for First Quarter 2007 Financial Results Announcement
Mar 26, 07
08:54 ET	Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Mar 22, 07
00:01 ET	Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership
Mar 14, 07
12:00 ET	Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Mar 09, 07
17:00 ET	Lilly Oncology on Canvas(SM) Kicks Off 2007 World Tour With Month-Long Exhibition in Indianapolis
Mar 05, 07
08:00 ET	Lilly Announces Acquisition of Hypnion
Feb 26, 07
06:00 ET	Lilly Plans New Clinical Trial of Xigris(R)
Feb 14, 07
12:48 ET	Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents
Feb 12, 07
15:29 ET	Scholarship Recognizes Adults With Attention-Deficit/Hyperactivity Disorder Striving for Academic Excellence
11:14 ET	PQIP Improves Medicaid Quality Of Care For Individuals With Mental Illness
Jan 31, 07
06:30 ET	Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and Reported EPS of $2.45
Jan 29, 07
16:30 ET	Lilly Announces Completion of ICOS Corporation Acquisition
Jan 16, 07
07:00 ET	Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
Jan 11, 07
10:00 ET	Lilly Announces Strategic Changes to its Global Manufacturing Operations
Jan 05, 07
08:00 ET	Lilly and OSI Pharmaceuticals Announce Licensing Agreement
Jan 04, 07
10:36 ET	Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
09:12 ET	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2006 Financial Results Announcement
08:00 ET	Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Dec 21, 06
13:40 ET	Eli Lilly and Company Statement Regarding Today's New York Times Article - December 21, 2006
07:00 ET	Data Monitoring Committee Recommends Closing Enrollment in Recurrent Glioblastoma Study
Dec 18, 06
15:30 ET	Lilly Announces Dividend Increase
12:46 ET	Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
Dec 07, 06
07:00 ET	Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
06:30 ET	Lilly Delivers Promising Update to Wall Street on Strategic Priorities, Pipeline Progress and Earnings Guidance
Dec 06, 06
07:00 ET	'This is Not a Dress Rehearsal' Captures Cancer Patient's Spirit and Wins Lilly Oncology on Canvas(SM) Art Competition
Nov 21, 06
06:30 ET	BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
Nov 20, 06
09:00 ET	Deadline Extended to Submit Nominations for Depression Awards Program
Nov 13, 06
13:30 ET	Eli Lilly and Company Foundation To Fund World-Class Diabetes Treatment and Care Program at Riley Hospital for Children
09:00 ET	Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
Nov 03, 06
05:30 ET	'Hair Again' Gives Cancer Journey Meaning
Oct 27, 06
08:00 ET	Study Suggests Strattera(R) was Effective in Treating ADHD in Children and Adolescents with ADHD and Reading Disorders
Oct 23, 06
11:30 ET	New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
08:30 ET	Lilly Expands Biotech Capabilities to Match Expanding Biotech Pipeline
Oct 20, 06
07:00 ET	Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer
Oct 19, 06
07:00 ET	Lilly ICOS LLC Reports Record Sales for Third Quarter of 2006
07:00 ET	Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS for Third Quarter
Oct 18, 06
17:50 ET	In Response to a Letter to the Editor That Appears in the Oct. 19, 2006, Issue of the New England Journal of Medicine, Eli Lilly and Company Provides the Following Statement:
Oct 17, 06
08:15 ET	Lilly Announces Acquisition of ICOS Corporation
Oct 16, 06
15:13 ET	Lilly Declares Fourth-Quarter Dividend
Oct 10, 06
08:00 ET	Eli Lilly and Company Announces 2006 Lilly Reintegration Awards Recipients
Sep 29, 06
08:30 ET	Lilly Announces FDA Requirement of Additional Clinical Trial Before Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy
Sep 28, 06
08:00 ET	2006 Lilly Oncology on Canvas(SM) International Art Competition Receives More Than 2,000 Entries
Sep 27, 06
13:00 ET	Lilly Seeks Entries for the Second Annual Adult ADHD Focus on Your Possibilities Scholarships
Sep 26, 06
12:12 ET	Government Approves Lilly's Medicare Part D Patient Assistance Program
Sep 25, 06
11:59 ET	Lilly Sets Date and Conference Call for Third Quarter 2006 Financial Results Announcement
Sep 21, 06
14:14 ET	Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes
Sep 16, 06
07:45 ET	New Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine
Sep 14, 06
11:00 ET	Lilly Celebrates 10 Years of Better Mealtime Blood Sugar Control with Humalog(TM)
08:00 ET	Lilly Receives NCQA Program Design Certification for Several Disease Management Programs
08:00 ET	Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
05:00 ET	Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
Sep 12, 06
09:05 ET	Awards Program Seeks to Honor Five Innovators in the Depression Community
08:00 ET	Lilly Announces LillyforLife(TM) Achievement Award Winners
Sep 11, 06
09:16 ET	Oncology Researchers Recognized as Heroes of Chemistry
Sep 08, 06
12:00 ET	Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Aug 31, 06
08:00 ET	Lilly's Taurel Calls for Japan-U.S. Economic Integration Agreement
Aug 18, 06
08:00 ET	Eli Lilly and Company Announces Approvable Letter Issued by FDA for Arxxant(TM) (ruboxistaurin mesylate)
Jul 28, 06
12:00 ET	Mental Health Prescription Program Announces Extension Through 2006
Jul 25, 06
08:30 ET	Older Does Not Always Mean Wiser: Survey Finds Postmenopausal Women Less Concerned About Breast Cancer Than Younger Women
Jul 21, 06
07:00 ET	Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006
07:00 ET	Lilly Reports Second-Quarter EPS of $.76
07:00 ET	Lilly and Alcon Sign Marketing Collaboration for Potentially the First Oral Medication for Diabetic Retinopathy
Jul 17, 06
09:57 ET	FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment
Jun 26, 06
08:35 ET	Lilly Declares Third-Quarter Dividend
Jun 22, 06
15:26 ET	Lilly Sets Date and Conference Call for Second Quarter 2006 Financial Results Announcement
08:00 ET	Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction
Jun 11, 06
18:15 ET	Investigational Treatment Ruboxistaurin Demonstrated Promise in Reducing the Occurrence of Vision Loss Caused by Diabetic Retinopathy
Jun 10, 06
12:15 ET	BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD
12:15 ET	Data on AIR(R) Inhaled Insulin System Presented at American Diabetes Association Meeting
10:00 ET	BYETTA(R) Extension Study Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years
10:00 ET	New Study Illustrates Economic Benefit of Weight Loss in People with Type 2 Diabetes
10:00 ET	Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
Jun 04, 06
14:00 ET	Lilly Announces Phase II Results for ALIMTA(R) in First-Line Metastatic Breast Cancer Trial
14:00 ET	New Data Show Enzastaurin's Activity Across Multiple Cancer Cell Lines
08:00 ET	Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel
Jun 03, 06
16:45 ET	Lilly Breast Cancer Studies Explore Potential Role of Pharmacogenomics in Customizing Chemotherapy
Jun 02, 06
07:00 ET	Lilly Launches New Award To Promote Enlightened Oncology Reporting
May 31, 06
07:00 ET	Lilly Launches Phase III Trial of Once-Daily, Targeted Oral Cancer Agent
May 24, 06
12:00 ET	Study Suggests Atomoxetine Significantly Improved Functioning in Children with Both ADHD and Anxiety Disorders
May 23, 06
15:00 ET	New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
08:00 ET	Lilly Oncology Prepares for Strong Showing at ASCO 2006; Targets Breast Cancer and Other Tumors with 79 Studies
May 22, 06
15:00 ET	First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
15:00 ET	New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
12:16 ET	Lilly Offers Tips for Disaster Preparation for Diabetes
May 19, 06
08:03 ET	2006 Welcome Back Awards Winners Honored for Helping Reshape the Mental Health System
May 10, 06
12:00 ET	Lilly to Extend Patient Assistance Programs for Medicare Patients
May 09, 06
08:03 ET	Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
May 04, 06
11:33 ET	Jury Issues Verdict in Ariad v. Lilly Patent Infringement Suit
Apr 24, 06
14:55 ET	Lilly Declares Second-Quarter Dividend
Apr 20, 06
07:00 ET	Lilly ICOS LLC Reports Results for First Quarter of 2006
07:00 ET	Lilly Reports Q1 EPS of $.77, or 13% Growth
Apr 18, 06
08:03 ET	National Survey Emphasizes Women Need More Comprehensive Approach to Managing Depression
Apr 17, 06
14:15 ET	Lilly Statement on STAR
Apr 12, 06
07:00 ET	Lilly Announces Preliminary Coronary and Breast Cancer Results from Raloxifene Use for The Heart (RUTH) Study
Apr 06, 06
09:45 ET	New Data Show Cialis(R) (tadalafil) is Effective in Treating Erectile Dysfunction Caused by Traumatic Spinal Cord Injury
08:01 ET	Study Examines Continued Economic Burden of Acute Coronary Syndrome Despite Standard Medical Interventions
Apr 01, 06
08:00 ET	CATIE Phase 2 Data Confirm Patients Stay on Treatment Longer Because of Symptom Improvement More So Than Tolerability
Mar 30, 06
10:30 ET	Lilly Announces Senior Leadership Changes
Mar 29, 06
02:00 ET	Call for Journalists to Enter the Embrace Award for Accurate, Responsible and Sensitive Reporting of Urinary Incontinence
Mar 24, 06
08:00 ET	Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder
Mar 22, 06
16:16 ET	Lilly Sets Date and Conference Call for First Quarter 2006 Financial Results Announcement
Mar 20, 06
07:01 ET	Lilly and Biosite to Collaborate on Clinical Trial Using Tailored Xigris Therapy
Mar 14, 06
14:00 ET	Study Shows More Potent and More Reliable Platelet Inhibition with Prasugrel Compared to Clopidogrel Even in Patients With More Reactive Platelets
Mar 09, 06
06:00 ET	Lilly Launches Phase III Trial of Targeted Cancer Agent
Feb 23, 06
09:20 ET	Lilly's Charles E. Golden Announces Retirement
Feb 21, 06
08:32 ET	Lilly Global Philanthropy Exceeds $500 Million in 2005
Feb 15, 06
06:04 ET	Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)
Feb 14, 06
08:06 ET	Study Finds Cymbalta(R) Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain
Feb 07, 06
08:15 ET	Lilly Launches Humalog(R) Mix50/50(TM) Insulin in United States
Feb 03, 06
13:56 ET	Combating Cancer with Color and Canvas: Lilly Oncology on Canvas(TM) International Art Competition Call for Entries
Jan 26, 06
06:30 ET	Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
Jan 24, 06
06:30 ET	Women's First Pregnancy and Delivery Creates Risk for Stress Urinary Incontinence (SUI)
Jan 20, 06
07:30 ET	Lilly ICOS LLC Reports First Full-Year Profit in its History
Jan 18, 06
08:04 ET	LillyforLife(TM) Ambassador Kris Freeman Named to 2006 U.S. Olympic Ski Team
Jan 03, 06
14:00 ET	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2005 Financial Results Announcement
Dec 22, 05
08:30 ET	Lilly to Take Asset Impairment Charges in Fourth Quarter of 2005
Dec 21, 05
08:00 ET	Lilly Resolves Investigation of Its Evista Marketing and Promotional Practices
Dec 20, 05
08:00 ET	New Study Showed No Difference in Total Treatment Costs When Comparing Those Starting Treatment with Older Conventional Antipsychotics and Those Starting Treatment with Zyprexa(R), an Atypical Antipsychotic, in the Treatment of Schizophrenia
Dec 19, 05
14:29 ET	Lilly Announces Dividend Increase
Dec 13, 05
09:00 ET	New Study Suggests Cymbalta(R) Reduced Depression Symptoms At Least As Fast As a Leading Competitor
Dec 10, 05
09:15 ET	Investigational Targeted Therapy May Offer Progress for Non-Hodgkin's Lymphoma Patients
Dec 09, 05
07:00 ET	Lilly Plans to Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application for Generalized Anxiety Disorder
07:00 ET	Lilly Tells Wall Street It's Uniquely Positioned To Deliver Sustained Growth
Nov 17, 05
09:03 ET	Deadline Extended to Submit Nominations for Depression Awareness Award
Nov 10, 05
07:00 ET	National Survey Finds Weight Gain, Patient-Provider Communication and New Medical Options Critical Factors for Controlling Type 2 Diabetes
Nov 08, 05
15:07 ET	From the Gridiron to the State House to Cable Television: Champions in Fight Against Mental Illness to be Honored by Lilly
Nov 07, 05
09:05 ET	November 14 Deadline Approaching to Submit Nominations for Depression Awareness Award
Nov 02, 05
06:16 ET	European School of Oncology Presents 2005 ACE Reporter Awards
Oct 31, 05
06:19 ET	2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries
Oct 20, 05
07:01 ET	Lilly ICOS LLC Reports First Quarterly Profit in its History
07:00 ET	Lilly Reports $.73 EPS and 10 Percent Sales Growth in the Third Quarter
Oct 17, 05
15:10 ET	Lilly Declares Fourth-Quarter Dividend
14:42 ET	J. Erik Fyrwald Elected to Lilly Board of Directors
08:31 ET	Early-Phase Data Show Prasugrel Demonstrates More Consistent Platelet Inhibition Compared to Clopidogrel
Oct 13, 05
12:00 ET	Lilly Announces Scholarship Recipients for Those Battling Severe Mental Illness
08:01 ET	Lilly Receives NCQA Certification for Its Two Latest Disease Management Programs
Oct 05, 05
09:37 ET	From Relationships to Working Lives: New Global Survey Reveals the True Impact and Emotional Burden of SUI Symptoms on Women
Sep 29, 05
08:01 ET	Lilly Announces Important Strattera(R) Label Update
Sep 28, 05
12:33 ET	2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries
Sep 22, 05
15:00 ET	Lilly Sets Date and Conference Call for Third-Quarter 2005 Earnings Announcement
09:02 ET	Lilly Hits One-Year Milestone of Commitment to Disclosure of Clinical Trial Results
Sep 21, 05
10:01 ET	World Tour of 'Lilly Oncology on Canvas' Art Exhibit Stops at D.C.'s Historic Union Station
Sep 20, 05
10:07 ET	Mountain Climber Reaches First Peak As Part Of Expedition To Help People Battling Depression
09:00 ET	Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?
08:31 ET	Lilly Announces Promotion of John C. Lechleiter to President and Chief Operating Officer
Sep 19, 05
13:37 ET	According to CATIE, Zyprexa(R) More Effective on Discontinuation Rate than Other Antipsychotics Studied
Sep 12, 05
07:13 ET	Long-Term Data on Exenatide Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People With Type 2 Diabetes
07:13 ET	Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy
07:12 ET	Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin
07:11 ET	Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine
Sep 06, 05
07:12 ET	Burden of ADHD Greater than Asthma, According to New Study
Aug 31, 05
13:00 ET	Lilly Provides Financial Support, Product Donations in Wake of Hurricane Katrina
08:02 ET	Focus on Your Possibilities ADHD Scholarship Winners Announced
Aug 25, 05
07:39 ET	Journalists Recognised for Excellence in Reporting on One of the Last Medical Taboos
Aug 11, 05
10:12 ET	First of its Kind Urinary Incontinence Study Reveals Many Women With Stress Urinary Incontinence Symptoms Receive Off-Label Medications or None at All
Aug 08, 05
17:00 ET	New Study Provides In-Depth Look at How Osteoporosis Treatments Function Within Bone
Aug 02, 05
15:30 ET	Lilly Announces Support of Drug Industry Principles on Consumer Advertising of Prescription Medicines
09:02 ET	Lilly Will Submit Ruboxistaurin Mesylate (Arxxant(TM)) to FDA for Treatment of Diabetic Retinopathy in 2005
Jul 21, 05
10:00 ET	Lilly ICOS' Cialis(R) (tadalafil) Reaches $1 Billion Global Sales Milestone
07:01 ET	Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since launch, exceed $1 billion -
07:00 ET	Lilly Reports Results for Second Quarter; Sales Increase 3 Percent
Jul 06, 05
03:00 ET	Lilly Licenses Oral DPP-IV Inhibitor from Taisho Pharmaceutical
Jul 05, 05
05:30 ET	Thoracic Cancer Patients Find New Reasons for Hope with Alimta(R)
05:30 ET	Treating Lung Cancer Patients Earlier May Improve Outcomes
Jun 29, 05
10:00 ET	Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level
Jun 24, 05
15:49 ET	Lilly Declares Third-Quarter Dividend
Jun 14, 05
13:00 ET	Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin
Jun 12, 05
18:30 ET	Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy
Jun 11, 05
13:00 ET	Aggressive Diabetes Education Program Makes Positive Impact on Health of Medicaid Patients
13:00 ET	New Data Show Cymbalta Improved Physical, Social and Emotional Functioning and Overall Health of Patients With Painful Diabetic Neuropathy
Jun 10, 05
19:15 ET	Long-Term Data on BYETTA(TM) Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People with Type 2 Diabetes
17:30 ET	Study Shows BYETTA(TM) Improves Blood Sugar Levels as Effectively as Insulin Glargine
Jun 09, 05
19:30 ET	Lilly and Plaintiffs' Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa(R) Product Liability Litigation
12:34 ET	Lilly Sets Date and Conference Call for Second-Quarter 2005 Earnings Announcement
08:03 ET	Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available
Jun 08, 05
08:00 ET	New Scholarship Program to Help Adults Living With ADHD Focus on Their Possibilities
Jun 02, 05
08:00 ET	Lilly Announces Winners in Global Awards for Outstanding Achievements in Diabetes Care
May 31, 05
12:22 ET	Lilly Announces Senior Leadership Changes
09:45 ET	Mountain Climber Leads Expedition of Hope for People Battling Depression
May 26, 05
11:00 ET	Regardless of Insurance Coverage, New Research Shows Vast Majority of People with Depression Are Not Effectively Treated
May 24, 05
17:09 ET	New Analysis Shows Cymbalta Reduced Anxiety Symptoms in Elderly Patients with Depression
15:00 ET	New Analysis Highlights Gender Differences in ADHD Patients Treated with Atomoxetine
15:00 ET	New Data Suggest Once-Daily Atomoxetine May Provide Symptom Relief for Up to 24 Hours
12:00 ET	First Head-to-Head Study Shows Patients with Bipolar Depression Had Greater Symptom Improvement on Olanzapine and Fluoxetine HCl Capsules than Lamotrigine
09:01 ET	National Coalition for Homeless Veterans Uniting Government and Public and Private Efforts to End Homelessness Among Veterans
May 23, 05
15:00 ET	New Study Showed Efficacy was Most Important Factor in Decision to Stay on Antipsychotic Treatment for Schizophrenia
14:20 ET	Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions
May 18, 05
09:25 ET	Non-Stimulant Strattera More Widely Available for Attention-Deficit/Hyperactivity Disorder Patients in Europe
09:01 ET	Non-stimulant Strattera More Widely Available for Attention- Deficit/Hyperactivity Disorder in Children and Adolescents in Europe
May 17, 05
08:02 ET	New Data Show Gemzar(R)-Based Combination Therapies May Provide Significant Clinical Value in Early-Stage Non-Small Cell Lung Cancer
07:45 ET	Lilly Targeted Agent Shows Promise in Treating Primary Brain Cancer
07:27 ET	New York Psychiatrist Wins Prestigious National Mental Health Award
May 16, 05
16:40 ET	NAMI-San Diego President Wins National Lifetime Achievement Award
16:21 ET	Boston-Area Author Wins Prestigious National Mental Health Award
16:21 ET	Connecticut Latina Wins Prestigious National Mental Health Award
15:41 ET	Oregon Mental Health Program Founder Wins National Award
15:26 ET	Northern Arizona Woman Wins National Mental Health Award
15:15 ET	Welcome Back Awards Honors Unsung Heroes in the Depression Community
14:15 ET	Lilly Does Not Endorse Below-Market Offer by TRC for 0.2 Percent of Lilly's Stock
12:15 ET	New Study Results Demonstrate Clinical Effectiveness of Gemzar(R)-Based Combination Therapy for Advanced Breast Cancer
10:00 ET	World Tour Of 'Oncology on Canvas' Art Exhibit To Make U.S. Debut At Harrison Center For The Arts In Indianapolis
May 03, 05
10:00 ET	Eli Lilly and Company Opens Nominations for 9th Annual Reintegration Awards
May 02, 05
14:28 ET	Pain Worsens Physical and Financial Burdens for Adults with Depression Nearing Retirement, Six-Year Study Shows
Apr 29, 05
10:07 ET	Lilly and Amylin Announce FDA Approval of Exenatide
07:30 ET	Amylin and Lilly Announce FDA Approval of BYETTA(TM) (Exenatide) Injection
Apr 18, 05
16:03 ET	Lilly Declares Second-Quarter Dividend
09:15 ET	Lilly ICOS LLC Reports Results for First Quarter of 2005
07:00 ET	Lilly Reports $.68 Earnings Per Share in the First Quarter
06:50 ET	Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France
06:01 ET	Lilly ICOS' Cialis(R) (tadalafil) Leads ED Market in France
Apr 14, 05
17:58 ET	U.S. District Court Rules in Favor of Lilly; Upholds Company's 2011 Patent on Zyprexa
Apr 13, 05
11:44 ET	U.S. District Court To Issue Ruling in the Zyprexa Patent Case on April 14 at 5:50 p.m. EDT
08:01 ET	Eli Lilly and Company Pledges $12.5 Million to Accelerate Cancer Clinical Research
Apr 11, 05
04:00 ET	Unique New Study Suggests Significant Benefits of Yentreve(R) in Combination with Pelvic Floor Muscle Training for Women with Stress Urinary Incontinence
Apr 07, 05
13:55 ET	Spine Imaging Improves the Identification of Future Fracture Risk in Postmenopausal Women With Osteoporosis
Apr 06, 05
12:00 ET	Studies Show Schizophrenia Patients Taking Atypicals Stayed on Treatment Longer Than Patients Taking Older, Typical Antipsychotics
Mar 15, 05
09:49 ET	Lilly Sets Date and Conference Call for First-Quarter 2005 Earnings Announcement
07:58 ET	Emmy Winning Actress Leads Charge to Pair People Battling Depression With Partners
Mar 09, 05
09:45 ET	Results of Early Data Show More Consistent Platelet Inhibition with Prasugrel Compared to Clopidogrel Across Three Distinct Trials
Mar 07, 05
08:58 ET	New Study Data Show Improved Cognitive Function in Elderly Patients Treated with Cymbalta for Depression
Mar 02, 05
09:00 ET	New BASS Sponsor Cialis(R) (tadalafil) Showcases Interactive Presence in Augusta
Feb 28, 05
09:00 ET	PGA TOUR Partner Cialis(R) (tadalafil) Debuts 2005 Consumer Golf Plans at The Ford Championship at Doral
Feb 10, 05
08:02 ET	Statement to the Media: Lilly ICOS Pleased with European Patent Office's Decision to Affirm Revocation of Pfizer's Patent on Treatment of Erectile Dysfunction
08:00 ET	The Larry King Cardiac Foundation Receives $100,000 Grant from Lilly to Support 'Save a Heart a Day'
Feb 07, 05
08:01 ET	Lilly Announces Individual Bar Coding on All Insulin Vials
Feb 01, 05
10:00 ET	Lilly's Taurel Says American Health System is Unhealthy to the Core
Jan 28, 05
09:16 ET	Lilly Reconfirms Its Financial Guidance
09:15 ET	Lilly and Boehringer Ingelheim Jointly Announce the Recision of U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence
Jan 27, 05
07:18 ET	Eli Lilly and Company Responds to BMJ Apology and Retraction
Jan 26, 05
07:01 ET	Lilly ICOS LLC Reports Results for 2004
07:00 ET	Lilly Delivers 10 Percent Top Line Growth for Full Year 2004
Jan 24, 05
10:00 ET	Cialis(R) (tadalafil) Joins BASS as Premiere Sponsor
Jan 13, 05
06:30 ET	Lilly Launches Public Outreach Initiative to Correct Allegations About Company and Prozac
Jan 06, 05
10:04 ET	Lilly Revises Conference Call Time for Fourth-Quarter and Full-Year 2004 Earnings Announcement
Jan 05, 05
16:47 ET	Lilly Affirms: No 'Missing' Prozac Documents and No New Scientific Information
12:00 ET	Lilly Provides Financial Support and Medicines for Tsunami Relief in Southeast Asia
11:38 ET	New Treatment for Depression Approved in Europe
Jan 03, 05
12:59 ET	Deadline Extended to Submit Nominations for Depression Awards Program
Dec 31, 04
15:12 ET	Lilly Issues Response to British Medical Journal
Dec 21, 04
09:59 ET	J. Michael Cook Elected to Lilly Board of Directors
Dec 20, 04
15:08 ET	Lilly Announces Dividend Increase
Dec 17, 04
07:30 ET	Lilly Announces Important Liver Safety Update to Strattera(R) Label
Dec 14, 04
09:01 ET	Study Demonstrated Long-Term Treatment with Zyprexa(R) Reduced Violent Behavior in People with Schizophrenia Compared to Risperidone
Dec 13, 04
13:56 ET	Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2004 Earnings Announcement
Dec 09, 04
07:00 ET	Lilly Profiles Its Exceptional New Product Flow and Pipeline to Wall Street
Dec 08, 04
06:00 ET	Lilly Launches Online Clinical Trial Registry at www.lillytrials.com: Company to Publish Results for All Lilly Marketed Products and Initiation of All Phase II - IV Clinical Trials
Dec 07, 04
10:01 ET	U.S. Winners of Oncology on Canvas International Art Competition Announced at San Antonio Breast Cancer Symposium
Dec 03, 04
00:01 ET	Lilly ICOS Celebrates a 'Promising' First Year of Cialis(R) (tadalafil) in the U.S.
Dec 02, 04
12:34 ET	Winners Announced Today at the Royal College of Art for the Oncology on Canvas International Art Competition Presented by Eli Lilly and Company
Nov 11, 04
08:03 ET	Eli Lilly and Company Honors U.S. Senator Gordon Smith and Others Whose Extraordinary Efforts Help People with Mental Illness Move Their Lives Forward
Nov 01, 04
02:00 ET	Lung Cancer Patients May Benefit From More Time Without Life-Threatening Chemotherapy Side Effects
Oct 27, 04
08:31 ET	Lilly Acquires Novel Compound for Insomnia from Merck KGaA
Oct 26, 04
09:01 ET	Awards Program Seeks Nominations Honoring Heroes of Depression Community
08:00 ET	Data Indicate That Lilly's Ruboxistaurin May Have A Potentially Beneficial Effect on Diabetes-Induced Eye Disease
Oct 25, 04
10:32 ET	Lilly, Sankyo Announce Start of Phase 3 Clinical Trial of Antiplatelet Agent
10:27 ET	Lilly Helps Thousands of Needy Hoosier Seniors with Cost of Medications
Oct 21, 04
08:45 ET	Lilly Announces Third-Quarter Earnings Per Share of $.69; Company Also Details Restructuring Activities
08:45 ET	Lilly ICOS LLC Reports Third Quarter 2004 Cialis Worldwide Sales of $154 Million
Oct 20, 04
14:49 ET	New Analysis Shows Lilly ICOS' Cialis(R) (tadalafil) is Effective in Treating ED in Men with Enlarged Prostates
Oct 18, 04
19:29 ET	Lilly Cautions Against Effects of Drug Importation
16:20 ET	Lilly Declares Fourth-Quarter Dividend
09:34 ET	Cymbalta(R) Provided Sustained Pain Relief for Women with Fibromyalgia, Study Shows
Oct 14, 04
14:15 ET	Lilly Commends Surgeon General's Report on Bone Health
Oct 04, 04
21:00 ET	Analysis Showed Teriparatide Reduced Fracture Risk Independent of Bone Turnover
Oct 03, 04
19:30 ET	Number, Severity of Fractures, Predicts Future Risk
Sep 24, 04
04:00 ET	New Study Shows Women with Severe Stress Urinary Incontinence May Reconsider Surgery After Experiencing the Benefits of Yentreve(R)
Sep 22, 04
13:06 ET	Lilly Receives NCQA Certification for Five Disease Management Programs
09:00 ET	NewsMaker Forum to Examine Barriers to Cancer Prevention Research
Sep 17, 04
14:37 ET	Lilly Sets Date and Conference Call for Third-Quarter 2004 Earnings Announcement
03:24 ET	EU Scientific Committee Recommends Approval of Cymbalta(R) and Xeristar(R) for Treatment of Major Depressive Episodes
Sep 13, 04
02:30 ET	Yentreve(R), First and Only Widely Approved Pharmaceutical Option for the Treatment of Stress Urinary Incontinence Is Now Available
Sep 07, 04
08:31 ET	FDA Approves Antidepressant Cymbalta(R) for Treatment of Pain Caused by Diabetic Peripheral Neuropathy, Which Affects Up to 5 Million Americans
Aug 29, 04
06:00 ET	Lilly, Sankyo Release Phase 2 Data on Investigational Agent to Treat Certain Heart Disease Patients
Aug 26, 04
11:11 ET	Lilly Launches New Antidepressant Cymbalta(R)
Aug 19, 04
16:00 ET	Lilly ICOS' Cialis(R) (tadalafil) Shows Steady Growth in First Nine Months On the U.S. ED Treatment Market
12:16 ET	FDA Approves Lilly's Alimta(R) (pemetrexed) for the Second-Line Treatment of Advanced Lung Cancer
Aug 13, 04
07:00 ET	Yentreve(TM)* Receives Approval Across the European Union for the Treatment of Stress Urinary Incontinence in Women
Aug 06, 04
13:00 ET	Lilly's Pedro Granadillo Announces Retirement
Aug 04, 04
08:21 ET	FDA Approves Lilly's Cymbalta(R) for the Treatment of Depression
Aug 03, 04
08:07 ET	Lilly to Disclose Results of All Clinical Trials for Marketed Products Via a Publicly Available Registry
Jul 29, 04
08:04 ET	Duloxetine Clinical Study Results Show Improvement in Stress Urinary Incontinence in Women
03:00 ET	Gemzar(R) Combination Therapy Receives European Regulatory Approvals for Treatment of Ovarian Cancer
Jul 27, 04
13:33 ET	Alimta(R) Receives Positive Endorsement for Lung Cancer Approval from FDA Advisory Committee
Jul 22, 04
07:07 ET	Lilly ICOS LLC Reports Second Quarter 2004 Cialis Worldwide Sales of $137 Million
07:01 ET	Lilly Delivers Sixth Consecutive Quarter of Double-Digit Sales Growth
Jul 20, 04
11:13 ET	NewsMaker Forum To Highlight New Advancements In Alzheimer's Care
Jul 16, 04
10:48 ET	New Treatment Guidelines Cite ReoPro(R) Favorably for PCI in Acute Heart Attack Patients
Jul 15, 04
13:00 ET	Lilly Announces Senior Leadership Changes
Jul 12, 04
06:00 ET	Lilly ICOS Offers 'Cialis Promise' Program to Men with ED - Pays for a Competing Product if They are Not Satisfied
Jul 08, 04
09:00 ET	Indiana's HoosierRx Program Partners with Eli Lilly and Company to Educate Seniors and Persons with Disabilities on Prescription Drug Discount Choices
Jun 29, 04
02:00 ET	Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes and Improves Quality of Life for Women
Jun 28, 04
09:20 ET	Lilly Declares Third-Quarter Dividend
Jun 24, 04
16:06 ET	FDA Extends Action Date for Cymbalta(R) For Continued Analysis of Already-Submitted Data
08:24 ET	Alimta(R) Receives CHMP Positive Opinion for Two Cancer Indications
Jun 22, 04
15:09 ET	Lilly's June 29 Discussion with Pharmaceutical Sell-Side Analysts Available via Webcast
Jun 17, 04
15:44 ET	Lilly Sets Date and Conference Call for Second-Quarter 2004 Earnings Announcement
Jun 16, 04
07:00 ET	New Analysis Showed Early Patient Response to FORTEO(R) in Postmenopausal Women with Osteoporosis
Jun 15, 04
09:02 ET	National Osteoporosis Foundation, Lilly Team Up to Raise Funds and Awareness
Jun 14, 04
11:34 ET	'Adequate' Treatment Isn't Enough to Make Most Depressed Patients Become Symptom Free
Jun 08, 04
13:00 ET	Eli Lilly and Company Opens Nominations For 8th Annual Awards for Mental Health Initiatives
09:26 ET	Survey Shows Parents Likely to Modify ADHD Medication Over Summer, Despite Results Showing Treatment Helps Kids Beyond School
Jun 05, 04
14:00 ET	Study Data Shows Newly Approved Gemzar(R) Combination Represents Superior Treatment Outcomes in Frontline Metastatic Breast Cancer
10:01 ET	Humalog(R) Mix(TM) 75/25 vs Lantus(R) in Type 2 Diabetes
10:00 ET	Key Study Findings About Diabetic Microvascular Complications May Lead to Improved Screenings and Treatment for People with Diabetes
Jun 03, 04
09:04 ET	First Non-Stimulant ADHD Medication Available in the United Kingdom
Jun 02, 04
10:45 ET	Lilly Reconfirms Financial Expectations in Advance of Analyst Conferences
07:32 ET	Lilly ICOS' Cialis(R) (tadalafil) Makes Impressive Strides in First Six Months on the U.S. ED Treatment Market
May 27, 04
14:00 ET	U.S. Ski Champion and Eli Lilly and Company Recognize Outstanding Achievements in Diabetes
11:27 ET	'Oncology on Canvas' International Art Competition Kicks Off with a Call for Entries
May 19, 04
15:00 ET	Eli Lilly and Company Creates Entrepreneurial Opportunity For Formerly Homeless Veterans
14:59 ET	FDA Grants Approval for Lilly's Gemzar(R) in Combination with Taxol(R) as First-line Treatment for Metastatic Breast Cancer
May 18, 04
11:43 ET	Overcoming The Confusion - Will Seniors Access The Savings From The Government's New Drug Card Program?
09:02 ET	Lilly ICOS Announces Plans to Usher in Second Century of History and Tradition at the 2004 Cialis Western Open
May 10, 04
08:01 ET	Men with ED More Likely to Have High Blood Pressure
May 05, 04
15:00 ET	Symbyax(TM) Shown to Reduce Symptoms Associated With Suicidal Thinking in Patients With Bipolar Depression
09:01 ET	Cymbalta(R) Helped Patients with Depression Feel Better Fast, According to Pooled Data from Two 9-week Trials
May 04, 04
15:00 ET	Cymbalta(R) Safely Treats Diabetic Neuropathic Pain in 52-week Study
15:00 ET	Long-term Treatment with Zyprexa(R) Demonstrated Significant Improvement Versus Risperidone in Treating Negative Symptoms in People with Schizophrenia
15:00 ET	Strattera Improved ADHD Impairment, Improved Family Interactions
May 03, 04
11:00 ET	Cymbalta(R) Helped Patients with Depression Stay Better Longer, New Data Show
09:02 ET	Alimta(R) Showed Advances over Taxotere(R) in Second-Line Non-Small Cell Lung Cancer Study
Apr 28, 04
12:30 ET	Data Presented at AAN Show Improvement of Symptoms of Diabetic Peripheral Neuropathy in Patients Taking Ruboxistaurin
10:35 ET	Cymbalta(R) Significantly Reduced Diabetic Neuropathic Pain in Second Placebo-controlled Study
Apr 27, 04
12:07 ET	The Epidemic of Overweight - New Hope on the Horizon?
11:37 ET	Guidelines Include Strattera as a First-line ADHD Therapy Option
Apr 22, 04
12:12 ET	New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness
Apr 20, 04
14:16 ET	Boeing Taps InnoCentive to Bring R&D Challenges to Top Scientific Minds Worldwide
Apr 19, 04
16:32 ET	Lilly Declares Second-Quarter Dividend
07:01 ET	Lilly ICOS LLC Reports First Quarter 2004 Global Cialis Sales of $108 million
07:00 ET	Lilly Delivers Strong Double-Digit Sales Growth for the Fifth Consecutive Quarter
Apr 14, 04
08:08 ET	Defending Champion Tiger Woods Heads Field in 101st Western Open
Apr 06, 04
10:29 ET	Lilly Endows Two Chairs at the Oklahoma Medical Research Foundation with $6 Million Gift
Mar 30, 04
08:00 ET	FDA Approves Injectable Form of Lilly's Zyprexa(R)
Mar 25, 04
07:59 ET	U.S. Attorney's Office in Pennsylvania Investigating Lilly's Marketing Practices
Mar 24, 04
00:01 ET	Progress of Lilly MDR-TB Partnership Highlighted as Part of World TB Day
Mar 23, 04
08:07 ET	Lilly ICOS Enjoys Early Success For Cialis(R) in ED Marketplace, Surpasses Levitra(R) in New U.S. Prescriptions
Mar 22, 04
11:23 ET	New Data Offer Sobering Insights Into the Significance of Drug-Resistant Tuberculosis
Mar 12, 04
16:46 ET	Lilly Sets Date and Conference Call for First-Quarter 2004 Earnings Announcement
Mar 11, 04
15:06 ET	New PGA TOUR Partner Cialis(R) (tadalafil) Debuts Consumer Golf Plans at The Honda Classic
Mar 10, 04
08:00 ET	Lilly Launches Monthly NewsMaker Forum
Mar 02, 04
15:00 ET	Lilly's Taurel Foreshadows Unprecedented Age Wave Breaking Over American Society
Feb 18, 04
11:21 ET	Lilly Collaborates to Create Center of Excellence in Protein Sciences for Indiana
Feb 12, 04
17:22 ET	Lilly Completes Acquisition of Applied Molecular Evolution
Feb 11, 04
08:00 ET	Three Head-to-Head Studies Demonstrate That Zyprexa Delays Relapse in Patients with Schizophrenia Significantly Longer Than Other Competitors in Its Class
Feb 09, 04
09:55 ET	InnoCentive Expands Scientific Network Into Korea
08:00 ET	Large-Scale Study in the British Journal of Urology Shows More Than One Out of Three Women With Urinary Incontinence Suffer From Stress Urinary Incontinence
Feb 05, 04
11:41 ET	FDA Approves Alimta(R)-Cisplatin Combination For Treatment of Asbestos-Related Cancer
08:01 ET	Lilly Unveils Enhanced Effort to Combat Counterfeit Drugs
Feb 02, 04
06:35 ET	Injectable Zyprexa(R) Now Available in First Markets
Jan 29, 04
15:05 ET	Lilly ICOS LLC Reports Results for 2003
06:59 ET	Lilly Delivers Outstanding Sales Growth of 17 Percent in the Fourth Quarter
Jan 27, 04
08:00 ET	Lilly Expresses Concerns With Opinion of ADA Panel On Antipsychotic Drugs and Obesity and Diabetes
Jan 26, 04
15:04 ET	New Cialis(R) Ad to Debut During Super Bowl XXXVIII
Jan 23, 04
15:04 ET	Western Golf Association Announces Cialis(R) As New Title Sponsor of the 2004 Cialis Western Open
Jan 21, 04
07:52 ET	Lilly Unveils Participation in Medicare Prescription Drug Discount Card
Jan 14, 04
15:27 ET	FDA Approves Zyprexa(R) for Maintenance of Bipolar Disorder
Jan 12, 04
08:32 ET	Lilly Launches Third Venture Capital Fund
Jan 07, 04
16:51 ET	InnoCentive Gives Researchers and Scientists Access to the eBay Marketplace
12:21 ET	Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2003 Earnings Announcement
Jan 06, 04
16:52 ET	InnoCentive Sponsors the 91st Indian Science Congress
Jan 05, 04
08:02 ET	Lilly Announces 2004 Financial Guidance